Barbara Collins
About
In The Last Decade
Barbara Collins
74 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 1.8k
- Genetics 907
- Oncology 756
- Psychiatry and Mental health 317
- Endocrinology, Diabetes and Metabolism 260
Countries citing papers authored by Barbara Collins
This map shows the geographic impact of Barbara Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Collins more than expected).
Fields of papers citing papers by Barbara Collins
This network shows the impact of papers produced by Barbara Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Collins. The network helps show where Barbara Collins may publish in the future.
Co-authorship network of co-authors of Barbara Collins
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Collins. A scholar is included among the top collaborators of Barbara Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Collins. Barbara Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial breakdown → | 95 |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 20 | |
| 6 | 47 | |
| 7 | 24 | |
| 8 | 54 | |
| 9 | 11 | |
| 10 | 26 | |
| 11 | 42 | |
| 12 | 113 | |
| 13 | 131 | |
| 14 | 174 | |
| 15 | Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension. | 8 |
| 16 | 17 | |
| 17 | 48 | |
| 18 | 6 | |
| 19 | 13 | |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.